Literature DB >> 24943728

Positional OSA part 1: Towards a clinical classification system for position-dependent obstructive sleep apnoea.

M H Frank1, M J L Ravesloot, J P van Maanen, E Verhagen, J de Lange, N de Vries.   

Abstract

BACKGROUND: In 1984, Cartwright suggested that physicians should differentiate between patients with either positional obstructive sleep apnoea (POSA) or non-positional OSA. Treatment of POSA has advanced dramatically recently with the introduction of a new generation of positional therapy (PT), a small device attached to either the neck or chest which corrects the patient from adopting the supine position through a vibrating stimulus. Encouraging data have been published suggesting that this simple therapy successfully prevents patients with POSA from adopting the supine position without negatively influencing sleep efficiency, as well as allowing for good adherence. Unfortunately, evaluating the efficacy of PT and comparing results are hindered by the fact that there are no universally used POSA criteria. In 1984, Cartwright introduced the arbitrary cut-off point of a difference of 50% or more in apnoea index between supine and non-supine positions.
INTRODUCTION: The aim of this project was to introduce a new classification system, which ideally should identify suitable candidates for PT: patients that will benefit from a clinically significant improvement of their OSA with PT. The shared use of this classification can facilitate collection of data across multiple centres and comparison of results across studies. We report on the development and process that resulted in the Amsterdam Positional OSA Classification (APOC).
METHOD: A panel of three field experts were instructed to independently assign the diagnosis POSA to 100 randomly selected patients they considered likely to benefit from a clinically significant improvement of their OSA with PT. In a group setting, the completed lists were compared. Discrepancies were discussed until consensus was met. This resulted in the consensus standard used to calibrate the new classification. Using the nominal group technique, the APOC was developed.
RESULTS: The APOC criteria evolve around the percentage of total sleep time spent in either the worst sleeping position (WSP) or the best sleeping position (BSP) and the apnoea-hypopnoea index (AHI) in BSP. On applying APOC, one discriminates between the true positional patient, the non-positional patient and the multifactorial patient, whose OSA severity is influenced in part by sleep position. APOC has an increased sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) compared to previously applied POSA criteria in identifying patients that will benefit from positional therapy.

Entities:  

Mesh:

Year:  2014        PMID: 24943728     DOI: 10.1007/s11325-014-1022-9

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  17 in total

Review 1.  The undervalued potential of positional therapy in position-dependent snoring and obstructive sleep apnea-a review of the literature.

Authors:  M J L Ravesloot; J P van Maanen; L Dun; N de Vries
Journal:  Sleep Breath       Date:  2012-03-24       Impact factor: 2.816

2.  The effects of sleep posture and sleep stage on apnea frequency.

Authors:  R D Cartwright; F Diaz; S Lloyd
Journal:  Sleep       Date:  1991-08       Impact factor: 5.849

3.  Evaluation of a new simple treatment for positional sleep apnoea patients.

Authors:  J Peter van Maanen; Wietske Richard; Ellen R Van Kesteren; Madeline J L Ravesloot; D Martin Laman; Antonius A J Hilgevoord; Nico de Vries
Journal:  J Sleep Res       Date:  2011-10-22       Impact factor: 3.981

4.  Are we missing a simple treatment for most adult sleep apnea patients? The avoidance of the supine sleep position.

Authors:  Arie Oksenberg; Natan Gadoth
Journal:  J Sleep Res       Date:  2013-10-10       Impact factor: 3.981

5.  The nominal group as a research instrument for exploratory health studies.

Authors:  A H Van de Ven; A L Delbecq
Journal:  Am J Public Health       Date:  1972-03       Impact factor: 9.308

6.  Comparison of positional therapy to CPAP in patients with positional obstructive sleep apnea.

Authors:  Irene Permut; Montserrat Diaz-Abad; Wissam Chatila; Joseph Crocetti; John P Gaughan; Gilbert E D'Alonzo; Samuel L Krachman
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

7.  Accurate position monitoring and improved supine-dependent obstructive sleep apnea with a new position recording and supine avoidance device.

Authors:  James J Bignold; Jeremy D Mercer; Nick A Antic; R Doug McEvoy; Peter G Catcheside
Journal:  J Clin Sleep Med       Date:  2011-08-15       Impact factor: 4.062

8.  [Efficacy and longterm compliance of the vest preventing the supine position in patients with obstructive sleep apnea].

Authors:  S Wenzel; E Smith; R Leiacker; Y Fischer
Journal:  Laryngorhinootologie       Date:  2007-08       Impact factor: 1.057

9.  Treatment success with a mandibular advancement device is related to supine-dependent sleep apnea.

Authors:  M Marklund; M Persson; K A Franklin
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

10.  Effect of sleep position on sleep apnea severity.

Authors:  R D Cartwright
Journal:  Sleep       Date:  1984       Impact factor: 5.849

View more
  27 in total

Review 1.  Efficacy of the New Generation of Devices for Positional Therapy for Patients With Positional Obstructive Sleep Apnea: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Madeline J L Ravesloot; David White; Raphael Heinzer; Arie Oksenberg; Jean-Louis Pépin
Journal:  J Clin Sleep Med       Date:  2017-06-15       Impact factor: 4.062

2.  Floppy epiglottis during drug-induced sleep endoscopy: an almost complete resolution by adopting the lateral posture.

Authors:  P E Vonk; M J L Ravesloot; K M Kasius; J P van Maanen; N de Vries
Journal:  Sleep Breath       Date:  2019-04-24       Impact factor: 2.816

3.  Efficacy and long-term follow-up of positional therapy by vibrotactile neck-based device in the management of positional OSA.

Authors:  Eugenio De Corso; Rodolfo F Mastrapasqua; Antonella Fiorita; Stefano Settimi; Dario Antonio Mele; Pasqualina Maria Picciotti; Antonella Loperfido; Sabino Marrone; Grazia Rizzotto; Gaetano Paludetti; Emanuele Scarano
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

4.  Amsterdam positional OSA classification: the AASM 2012 recommended hypopnoea criteria increases the number of positional therapy candidates.

Authors:  Brett Duce; Antti Kulkas; Christian Langton; Juha Töyräs; Craig Hukins
Journal:  Sleep Breath       Date:  2016-11-11       Impact factor: 2.816

5.  The use of handheld nasal spirometry to predict the presence of obstructive sleep apnea.

Authors:  Judd H Fastenberg; Christina H Fang; Viraj M Patel; Juan Lin; Howard D Stupak
Journal:  Sleep Breath       Date:  2017-06-30       Impact factor: 2.816

6.  Clinical features in patients with positional obstructive sleep apnea according to its subtypes.

Authors:  Sang-Ahm Lee; Joon-Hyun Paek; Yoo-Sam Chung; Woo Sung Kim
Journal:  Sleep Breath       Date:  2016-07-12       Impact factor: 2.816

7.  Supine position and REM dependence in obstructive sleep apnea : Critical model considerations.

Authors:  A Steffen; L Maibücher; I R König
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

8.  The role of compact polysomnography/polygraphy in sleep breathing disorder patients' management.

Authors:  Marcello Bosi; Andrea De Vito; Claudio Vicini; Venerino Poletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

Review 9.  Positional therapy in the management of positional obstructive sleep apnea-a review of the current literature.

Authors:  Olabimpe Omobomi; Stuart F Quan
Journal:  Sleep Breath       Date:  2017-08-29       Impact factor: 2.816

Review 10.  Obstructive sleep apnoea syndrome and its management.

Authors:  Lucia Spicuzza; Daniela Caruso; Giuseppe Di Maria
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.